智通财经APP讯，中国生物科技服务(08037)发布公告，于2026年3月30日，根据公司薪酬委员会的建议，董事会已经议决根据股份奖励计划，按零代价向七名获选参与者授予合共450万股奖励股份，相当于本公告日期之已发行股份总数约0.46%，其须待承授人接纳后，方可作实。450万股奖励股份乃由受托人运用公司为受托人提供的内部资源从公开市场收购。参考股份于奖励股份授出日期的收市价每股0.81港元，该450万股奖励股份的市场价值为364.5万港元。
智通财经APP讯，中国生物科技服务(08037)发布公告，于2026年3月30日，根据公司薪酬委员会的建议，董事会已经议决根据股份奖励计划，按零代价向七名获选参与者授予合共450万股奖励股份，相当于本公告日期之已发行股份总数约0.46%，其须待承授人接纳后，方可作实。450万股奖励股份乃由受托人运用公司为受托人提供的内部资源从公开市场收购。参考股份于奖励股份授出日期的收市价每股0.81港元，该450万股奖励股份的市场价值为364.5万港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.